Events
Webinar: Getting Gene Therapies to Market Faster with CBM’s Analytical Accelerator for Testing AAV
The Center for Breakthrough Medicines (CBM) offers comprehensive AAV testing services with the newly launched Analytical AcceleratorTM for AAV Testing. Given recent gene therapy approvals and a growing clinical pipeline, there is currently a severe shortage of Good Manufacturing Practices (GMP) testing capacity for AAV-based gene therapies, resulting in extremely long leads for key assays, …